Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionJohn J.V. McMurray, Anna-Maria Langkilde, Masafumi Kitakaze et al.|New England Journal of Medicine|2019Cited by 6.8k
Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D. Anker, Milton Packer, Javed Butler et al.|New England Journal of Medicine|2021Cited by 4.6k
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across RegionsMaría G. Crespo‐Leiro, Alexandre Mebazaa, Stefan D. Anker et al.|European Journal of Heart Failure|2016Cited by 781
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection FractionScott D. Solomon, Subodh Verma, John J.V. McMurray et al.|New England Journal of Medicine|2024Cited by 693
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trialDirk Sibbing, Ferenc Nagy, Dániel Aradi et al.|The Lancet|2017Cited by 588